Geneva, Switzerland · Founded 2019 · Privately Held (backing)
Developer of nuclear technology designed to address the problem of spent nuclear fuel by reducing its toxicity and long-term hazards. Transmutex is based in Geneva, Switzerland and was founded in 2019. Its last reported valuation was $24.9 million in Nov 2020. It has raised $45.7 million.
Last reported valuation
$24.9M
Nov 2026
Priced at
—
Total raised
$45.7M
Last round
—
Cap table — not yet on record
Transmutex's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Private Market View
Also on the Transmutex record at Private Market View
